Y Intercept Hong Kong Ltd bought a new position in Maximus, Inc. (NYSE:MMS – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 10,824 shares of the health services provider’s stock, valued at approximately $1,008,000.
Several other hedge funds and other institutional investors have also made changes to their positions in MMS. Assenagon Asset Management S.A. raised its position in Maximus by 151.6% in the 2nd quarter. Assenagon Asset Management S.A. now owns 233,134 shares of the health services provider’s stock worth $19,980,000 after purchasing an additional 140,481 shares during the period. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in Maximus by 942.9% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock valued at $27,707,000 after buying an additional 292,300 shares during the period. SG Americas Securities LLC increased its holdings in Maximus by 609.6% during the second quarter. SG Americas Securities LLC now owns 14,278 shares of the health services provider’s stock valued at $1,224,000 after buying an additional 12,266 shares during the period. Versor Investments LP increased its holdings in Maximus by 213.5% during the third quarter. Versor Investments LP now owns 8,500 shares of the health services provider’s stock valued at $792,000 after buying an additional 5,789 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its holdings in Maximus by 12.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider’s stock valued at $86,552,000 after buying an additional 102,350 shares during the period. Institutional investors own 97.21% of the company’s stock.
Wall Street Analysts Forecast Growth
Separately, StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research note on Thursday, November 28th.
Maximus Trading Down 0.5 %
NYSE:MMS opened at $70.67 on Friday. Maximus, Inc. has a 12 month low of $70.00 and a 12 month high of $93.97. The firm has a fifty day simple moving average of $83.01 and a 200-day simple moving average of $86.70. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $4.26 billion, a P/E ratio of 14.13 and a beta of 0.73.
Maximus Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Shareholders of record on Friday, November 15th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.70%. Maximus’s dividend payout ratio (DPR) is 24.00%.
Insiders Place Their Bets
In other news, insider Michelle F. Link sold 1,363 shares of the company’s stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the completion of the transaction, the insider now owns 6,567 shares in the company, valued at approximately $607,841.52. This represents a 17.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.40% of the stock is owned by corporate insiders.
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles
- Five stocks we like better than Maximus
- 3 REITs to Buy and Hold for the Long Term
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- Energy and Oil Stocks Explained
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- What is a Death Cross in Stocks?
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.